An MRI study of septi pellucidi in relation to hippocampus volume and fornix integrity in schizophrenia

Schizophrenia Research

Volumn 134, Issue 2-3, 2012, Pages 165-170

  Davidson, Charlie A ^a,c   Kuroki, Noriomi ^b   Alvarado, Jorge L ^a   Niznikiewicz, Margaret A ^b   McCarley, Robert W ^b   Levitt, James J ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Cavum septi pellucidi; Fornix; Hippocampus; MRI; Schizophrenia; Septum pellucidum

Indexed keywords

CHLORPROMAZINE;

ADULT; ARTICLE; BRAIN FORNIX; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIFFUSION TENSOR IMAGING; FEMALE; FIRST EPISODE SCHIZOPHRENIA; HIPPOCAMPUS; HUMAN; IMAGE PROCESSING; LONGITUDINAL STUDY; MALE; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SCHIZOPHRENIA; SEPTUM PELLUCIDUM;

ADULT; ANISOTROPY; ANTIPSYCHOTIC AGENTS; CHLORPROMAZINE; CROSS-SECTIONAL STUDIES; DIFFUSION TENSOR IMAGING; FEMALE; FORNIX, BRAIN; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; SCHIZOPHRENIA; SEPTUM PELLUCIDUM; YOUNG ADULT;

EID: 84856248867     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.11.012     Document Type: Article

References (39)

1. Andreasen N.C. Scale for the Assessment of Negative Symptoms (SANS) 1981, Department of Psychiatry, University of Iowa College of Medicine, Iowa City, IA.
2. Andreasen N.C. Scale for the Assessment of Positive Symptoms (SAPS) 1984, Department of Psychiatry, University of Iowa College of Medicine, Iowa City, IA.
3. Andy O.J., Stephan H. The septum in the human brain. J. Comp. Neurol. 1968, 133:383-410.
4. Beaton E.A., Qin Y., Nguyen V., Johnson J., Pinter J.D., Simon T.J. Increased incidence and size of cavum septum pellucidum in children with chromosome 22q11.2 deletion syndrome. Psychiatry Res. 2010, 181(2):108-113.
5. Brown A.S., Deicken R.F., Vinogradov S., Kremen W.S., Poole J.H., Penner J.D., Kochetkova A., Kern D., Schafer C.A. Prenatal infection and cavum septum pellucidum in adult schizophrenia. Schizophr. Res. 2009, 108(1-3):285-287.
6. Choi J.S., Kang D.H., Park J.Y., Jung W.H., Choi C.H., Chon M.W., Jun M.H., Lee J.M., Kwon J.S. Cavum septum pellucidum in subjects at ultra-high risk for psychosis: compared with first-degree relatives of patients with schizophrenia and healthy volunteers. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1326-1330.
7. Colom L.V., Garrido-Sanabria E. Modulation of normal and altered hippocampal excitability states by septal networks. J. Neurosci. Res. 2007, 85(13):2839-2843.
8. Dickey C.C., McCarley R.W., Xu M.L., Seidman L.J., Voglmaier M.M., Niznikiewicz M.A., Connor E., Shenton M.E. MRI abnormalities of the hippocampus and cavum septi pellucidi in females with schizotypal personality disorder. Schizophr. Res. 2007, 89:49-58.
9. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. The global assessment scale: a procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry 1976, 33(6):766-771.
10. Fitzsimmons J., Kubicki M., Smith K., Bushell G., Estepar R.S.J., Westin C.F., Nestor P.G., Niznikiewicz M.A., Kikinis R., McCarley R.W., Shenton M.E. Diffusion tractography of the fornix in schizophrenia. Schizophr. Res. 2009, 107:39-46.
11. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12(3):189-198.
12. Galarza M., Merlo A.B., Ingratta A., Albanese E.F., Albanese A.M. Cavum septum pellucidum and its increased prevalence in schizophrenia: a neuroembryological classification. J. Neuropsychiatry Clin. Neurosci. 2004, 16:41-46.
13. Hirayasu Y., Shenton M.E., Salisbury D.F., McCarley R.W. Hippocampal and superior temporal gyrus volume in first-episode schizophrenia. Arch. Gen. Psychiatry 2000, 57:618-619.
14. Hollingshead A. Two Factor Index of Social Position 1965, Yale University Press, New Haven, CT.
15. Kasai K., Shenton M.E., Salisbury D.F., Hirayasu Y., Onitsuka T., Spencer M.H., et al. Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 2003, 60:766-775.
16. Kasai K., McCarley R.W., Salisbury D.F., Onitsuka T., Demeo S., Yurgelun-Todd D., Kikinis R., Jolesz F.A., Shenton M.E. Cavum septi pellucidi in first-episode schizophrenia and first-episode affective psychosis: an MRI study. Schizophr. Res. 2004, 71:65-76.
17. Koo M., Levitt J., Salisbury D.F., Nakamura M., Shenton M.E., McCarley R. A cross-sectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis. Arch. Gen. Psychiatry 2008, 65:746-760.
18. Kubicki M., Westin C.F., Maier S.E., Frumin M., Nestor P.G., Salisbury D.F., Kikinis R., Jolesz F.A., McCarley R.W., Shenton M.E. Uncinate fasiculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study. Am. J. Psychiatry 2002, 159(5):813-820.
19. Kubicki M., Westin C.F., Nestor P.G., Wible C.G., Frumin M., Maier S., Kikinis R., Jolesz F.A., McCarley R.W., Shenton M.E. Cingulate fasciculus integrity disruption in schizophrenia: a magnetic resonance diffusion tensor imaging study. Biol. Psychiatry 2003, 54:1171-1180.
20. Kuroki N., Kubicki M., Nestor P.G., Salisbury D.F., Park H.J., Levitt J.J., Woolston S., Frumin M., Niznikiewicz M., Westin C.F., Maier S.E., McCarley R.W., Shenton M.E. Fornix integrity and hippocampal volume in male schizophrenic patients. Biol. Psychiatry 2006, 60:22-31.
21. Kwon J.S., Shenton M.E., Hirayasu Y., Salisbury D.F., Fischer I.A., Dickey C.C., Yurgelun-Todd D., Tohen M., Kikinis R., Jolesz F.A., McCarley R.W. MRI study of cavum septi pellucidi in schizophrenia, affective disorder, and schizotypal personality disorder. Am. J. Psychiatry 1998, 155:509-515.
22. Levitt J.J., Bobrow L.H., Lucia D.M., Srinivasan P. A selective review of volumetric and morphometric imaging in schizophrenia. Curr. Top. Behav. Neurosci. 2010, 4:243-281.
23. Nopoulos P., Swayze V., Flaum M., Ehrhardt J.C., Yuh W.T., Andreasen N.C. Cavum septi pellucid in normals and patients with schizophrenia as detected by magnetic resonance imaging. Biol. Psychiatry 1997, 41(11):1102-1108.
24. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9:97-113.
25. Onitsuka T., Shenton M.E., Kasai K., Nestor P.G., Toner S.K., Kikinis R., Jolesz F.A., McCarley R.W. Fusiform gyrus volume reduction and facial recognition in chronic schizophrenia. Arch. Gen. Psychiatry 2003, 60:349-355.
26. Overall J.E., Hollister L.E., Pichot P. Major psychiatric disorders: a four-dimensional model. Arch. Gen. Psychiatry 1967, 16(2):146-151.
27. Rajarethinam R., Sohi J., Arfken C., Keshavan M. No difference in the prevalence of cavum septum pellucidum (CSP) between first-episode schizophrenia patients, offspring of schizophrenia patients and healthy controls. Schizophr. Res. 2008, 103:22-25.
28. Rakic P., Yakovlev P.I. Development of the corpus callosum and cavum septi in man. J. Comp. Neurol. 1968, 132:45-72.
29. Raybaud C. The corpus callosum, the other great forebrain commissures, and the septum pellucidum: anatomy, development, and malformation. Neuroradiology 2010, 52:447-477.
30. Sarwar M. The septum pellucidum: normal and abnormal. Am. J. Neuroradiol. 1989, 10(5):989-1005.
31. Shenton M.E., Dickey C.C., Frumin M., McCarley R.W. A review of MRI findings in schizophrenia. Schizophr. Res. 2001, 49(1-2):1-52.
32. Shioiri T., Oshitani Y., Kato T., Murashita J., Hamakawa H., Inubushi T., Nagata T., Takahashi S. Prevalence of cavum septum pellucidum detected by MRI in patients with bipolar disorder, major depression and schizophrenia. Psychol. Med. 1996, 26(2):431-434.
33. Steen R.G., Mull C., McClure R., Hamer R.M., Lieberman J.A. Brain volume in first-episode schizophrenia. Br. J. Psychiatry 2006, 188:510-518.
34. Takahashi T., Suzuki M., Hagino H., Niu L., Zhou S.-Y., Nakamura K., Tanino R., Kawasaki Y., Seto H., Kurachi M. Prevalence of large cavum septi pellucid and its relation to the medial temporal lobe structures in schizophrenia spectrum. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:1235-1241.
35. Tombaugh T.N. Trail making test A and B: normative data stratified by age and education. Arch. Clin. Neuropsychol. 2004, 19:203-214.
36. Trzesniak C., Oliveira I.R., Kempton M.J., Almeida A.G., Chagas M.H.N., Ferrari M.C.F., Filho A.S., Zuardi A.W., Prado D.A., Busatto G.F., McGuire P.K., Hallack J.E.C., Crippa J.E.S. Are cavum septum pellucidum abnormalities more common in schizophrenia spectrum disorders? A systematic review and meta-analysis. Schizophr. Res. 2011, 125(1):1-12.
37. Wechsler D. Wechsler Adult Intelligence Scale-Revised 1981, Harcourt Brace Jovanovich Inc., New York, NY.
38. Wechsler D. Wechsler Adult Intelligence Scale 1997, The Psychological Corporation, San Antonio, TX. Third Edition.
39. Winter T.C., Kennedy A.M., Byrne J., Woodward P.J. The cavum septi pellucid: why is it important?. J. Ultrasound Med. 2010, 29(3):427-444.